logo
NSAB chairman Alok Joshi urges enhanced intelligence sharing among government agencies to break agency silos

NSAB chairman Alok Joshi urges enhanced intelligence sharing among government agencies to break agency silos

Time of India06-06-2025
NSAB chairman Alok Joshi urges enhanced intelligence sharing among government agencies to break agency silos
GANDHINAGAR: National Security Advisory Board chairman Alok Joshi on Thursday emphasised the need for intelligence sharing among govt agencies for better results and asserted that one of the challenges agencies face is breaking the silos in which they operate.
Joshi, who was addressing delegates at the 'Police Technology Summit 2025' at Rashtriya Raksha University in Gandhinagar, headed the Research and Analysis Wing (RAW) and the National Technical Research Organisation (NTRO), apex level agencies in the country's intelligence mechanism, before helming NSAB.
"India stands at a pivotal moment where technology can revolutionize law enforcement. However, success of this revolution depends on collecting data and analysing it, sharing it swiftly within and across agencies and recalibrating systems through feedback, all the while placing the human factor at the heart of our efforts," Joshi said in his address.
"One of the challenges that India is facing is breaking the silos without compromising on the principle of 'need to know'. I think that is something which is central to our system and it will not go away," the retired IPS officer said.
National Security Advisory Board chairman Alok Joshi gave an example of NTRO having refused to share an intelligence input when he was heading RAW. "When I was heading the RAW, we did an operation in the adversary country and the operation was a success, and we knew exactly what was going to be the pushback.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
เทรดทองCFDs กับโบรกเกอร์ที่เชื่อถือได้ | เรียนรู้เพิ่มเติม
IC Markets
สมัคร
Undo
Security levels were raised and precautions were taken," said Joshi. At that time, NTRO gave an input to RAW, indicating that there was "something brewing", Joshi said.
"So I reached out to the then chairman of NTRO and requested him to show me the excerpts of that intercept. Unfortunately, he took a different opinion. A view was taken that they cannot show the intercept because of certain security reasons. That was their assessment," he said.
"But this thing stuck in my mind. Within three months, I was in NTRO (as chief). After I settled, the first thing I did was to call for that file. And believe me, if the contents of that message had been shown to me, it would have been a different story. After all, we were both heading security organizations," Joshi said.
Asserting that analysing and operationalising intelligence is equally important, Joshi said all officials must remember that someone is the consumer of the information they are receiving.
"What would you expect the consumer to do with that information? I think this is something that has to be ingrained in the system, both at the time of collection, and at the time of dissemination," he said. He said no intelligence is complete without feedback, but it is equally difficult to get feedback on the input shared with other agencies.
"It is very difficult, but as a producer, it is your duty to chase it. Ensure that you get feedback or have a relationship with that organization where you have the trust and the confidence built in to give you that feedback," he added.
During his address, Joshi also said the govt should share the development cost incurred by entrepreneurs building indigenous technologies. "If you want to strengthen your indigenous effort, you have to pay the cost for it.
The development cost has to be shared by the govt. At NSAB, we have started taking a re-look at the procurement process, especially for policing and security agencies. It is necessary because you can't have a no cost-no commitment principle. Working in this kind of environment, it will just not work. It will not encourage the industry," he stressed.
Get the latest lifestyle updates on Times of India, along with
Eid wishes
,
messages
, and
quotes
!
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

BJP was never silent on Prajwal Revanna, law must take its course: Union Minister Pralhad Joshi
BJP was never silent on Prajwal Revanna, law must take its course: Union Minister Pralhad Joshi

Hindustan Times

time10 hours ago

  • Hindustan Times

BJP was never silent on Prajwal Revanna, law must take its course: Union Minister Pralhad Joshi

Union Minister Pralhad Joshi on Sunday dismissed allegations that the BJP had maintained silence on the conviction of former JD(S) MP Prajwal Revanna in a rape case, asserting that the party has consistently stood for legal accountability, regardless of political affiliations. Union minister Pralhad Joshi. (PTI) Also Read - Prajwal Revanna breaks silence after conviction in rape case: 'Only mistake was…' Responding to claims made by Congress leaders that the BJP was avoiding comment due to its alliance with the JD(S), Joshi told reporters, 'Where have we kept silent? And why should we? I have already spoken on this. If someone commits a crime, action must be taken, that's the BJP's clear position.' Joshi stressed that India's legal system is functioning independently and that court decisions must be respected. 'The court has examined the case and delivered its verdict. Whoever commits a crime must face the consequences. That applies to everyone,' he said. The minister's remarks come a day after a Bengaluru court sentenced Prajwal Revanna, the grandson of former Prime Minister HD Deve Gowda, to life imprisonment in connection with the rape of a 48-year-old domestic worker employed at his family's farmhouse in Hassan. The court also imposed a fine of ₹11.50 lakh, directing ₹11.25 lakh of it to be paid to the survivor. Revanna has been convicted in one of four cases filed against him, with three others still pending. Also Read - 'None of the women came forward voluntarily': What Prajwal Revanna told in court before conviction? Joshi also took a swipe at the Congress party, accusing it of political hypocrisy. 'Are there not people who committed heinous crimes and were part of the Congress? Yasin Malik was once associated with a former Prime Minister. There are many such examples, I don't want to name more,' he said. With JD(S) leader and Prajwal's uncle HD Kumaraswamy currently serving as a Union Minister in the Modi-led cabinet, the BJP has faced criticism over its ties with the regional party. However, Joshi reiterated that alliances do not interfere with the BJP's stance on law and justice. Addressing questions about Rahul Gandhi's planned protest in Bengaluru on August 5, Joshi questioned its purpose. 'What is the agitation for? Every time Congress loses an election, they blame the EVMs or the Election Commission. But when they win, there's no issue,' he said. (With PTI inputs)

'Irreplaceable For Americans': Pharmexcil Chief Says India's Low-Cost Drug Edge Can't Be Matched Overnight
'Irreplaceable For Americans': Pharmexcil Chief Says India's Low-Cost Drug Edge Can't Be Matched Overnight

News18

time14 hours ago

  • News18

'Irreplaceable For Americans': Pharmexcil Chief Says India's Low-Cost Drug Edge Can't Be Matched Overnight

Last Updated: The US remains dependent on India for affordable medicines – and that is unlikely to change anytime soon India has become too central to global drug supply to be marginalised – not even by the United States – so much so that it has made itself 'irreplaceable". The chief of India's pharmaceuticals export body, Namit Joshi told News18 that India exports 55 percent to the United States and United Kingdom – the most stringent markets in the world. 'We export 55% to the US and UK – the most stringent markets in the world. Imagine the level of compliance the Indian industry has achieved," said Joshi, who is the chairman of Pharmaceuticals Export Promotion Council of India (Pharmexcil), a body under the Ministry of Commerce and Industry. For Joshi, the latest tariff talk is more about politics than policy. 'There is a big difference between announcement and reality," he said. 'On diplomatic levels, such announcements, I believe, are made to enter into bilateral negotiations." He cited US President Donald Trump's repeated threats – to India, China, Canada, and Mexico. 'All those deals are still open. Talks are ongoing. Nothing conclusive yet… hence, there is no need to panic only about the announcements." Joshi is clear: the US cannot replicate India's drug ecosystem anytime soon. 'As much as Trump wants to MAGA (Make America Great Again), the US can't replace India," he said. 'Fixed costs in the US are too high, 42% of the population is obese, average chronic disease-free life is just 63 years – there's huge demand for medicines. But they don't have the talent or cost base to make them locally," he said. He added: 'For now, and for the foreseeable future, the world still needs Indian drugs. And India is ready to deliver." GLOBAL DEMAND, LOCAL FRAGILITY The US remains dependent on India for affordable medicines – and that's unlikely to change anytime soon. 'The US won't be able to develop our capabilities to manufacture low-cost drugs overnight," Joshi said. 'It will take at least two to three years to develop a local industry – and I'm not sure they'll find the right skill and talent even then," he said. India's cost advantage isn't the only barrier. 'We spend 12% of industry earnings just to maintain US FDA-approved facilities," he says. 'Countries like Pakistan, Bangladesh, China, Sri Lanka – they have all tried to compete. But they haven't matched us on quality or pricing, he added." China, despite its strength in chemicals and backward integration, still lags in formulations. 'It is a leader in producing KSMs and intermediaries, supplying to the globe, yet it is still not able to match India's capabilities and pricing." THE WORLD IS WATCHING – AND ALSO LEARNING Many governments may be pursuing localisation, but their strategies look very different from India's. 'Localising drug manufacturing is not everyone's play," Joshi said. 'The Netherlands is coming to iPHEX this year; they're developing a local pharma, but focused on high-end, expensive products. That won't hurt us. If anything, they're learning from us," he said. Pharmexcil is set to host its annual international expo, iPHEX, at Bharat Mandapam in New Delhi from September 4 to 6. For the first time, it is being organised without any financial support from the Centre. 'The event will host 350 international delegates from over 100 countries, including regulators, buyers, and policymakers. Exhibitors will showcase Indian strengths in APIs, formulations, diagnostics, digital health, biosimilars, and more," Joshi said. India's pharmaceutical exports have grown at a compound annual rate of 11 percent over the past decade, with a 9.54 percent increase last year alone. But Joshi knows generics alone won't fuel the future. 'The next growth lever will be achieved via innovation," he said. 'Biologics, CAR-T therapies, oncology, transplant medicines, super-speciality areas – this is where the next frontier lies." He cites Wockhardt's Zaynich as a made-in-India innovation that marks a turning point. 'We can plan our generic pipeline around upcoming patent expiries like Semaglutide, but original innovation is what will add real value." Get breaking news, in-depth analysis, and expert perspectives on everything from politics to crime and society. Stay informed with the latest India news only on News18. Download the News18 App to stay updated! tags : Pharmaceuticals view comments Location : New Delhi, India, India First Published: August 04, 2025, 09:00 IST News india 'Irreplaceable For Americans': Pharmexcil Chief Says India's Low-Cost Drug Edge Can't Be Matched Overnight Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.

ED freezes ₹17.4 crore assets in ₹200 crore Axis Mutual Fund front-running case; ex-fund manager arrested
ED freezes ₹17.4 crore assets in ₹200 crore Axis Mutual Fund front-running case; ex-fund manager arrested

Hindustan Times

time16 hours ago

  • Hindustan Times

ED freezes ₹17.4 crore assets in ₹200 crore Axis Mutual Fund front-running case; ex-fund manager arrested

MUMBAI: The Enforcement Directorate (ED) has frozen assets worth ₹17.4 crore in a multi-city crackdown linked to a ₹200 crore money-laundering case involving front-running trades at Axis Mutual Fund. The agency on Saturday also arrested the alleged kingpin, Viresh Joshi, who was the fund manager at Axis Mutual Fund during the time of the alleged offences. ED freezes ₹ 17.4 crore assets in ₹ 200 crore Axis Mutual Fund front-running case; ex-fund manager arrested The searches were carried out on Friday and Saturday at locations across Mumbai, Delhi, Gurugram, Ludhiana, Ahmedabad, Bhuj, Bhavnagar, and Kolkata under the Prevention of Money Laundering Act (PMLA). The frozen assets — considered proceeds of crime — include shares, mutual fund holdings, and bank balances. According to the ED, Joshi and others made illegal profits by engaging in front-running — an illicit trading practice where brokers or insiders exploit advance knowledge of large client trades to buy or sell stocks for personal gain. The trades were allegedly conducted between 2018 and 2021, using sensitive data from Axis Mutual Fund, which manages assets worth over ₹2 lakh crore. The ED said Joshi used a trading terminal in Dubai to execute these front-running orders through mule accounts obtained from multiple brokers. The investigation has so far identified proceeds of crime exceeding ₹200 crore, though officials believe the actual figure could be significantly higher. 'The funds were routed through a complex web of shell entities and accounts controlled by the accused, their associates, and family members,' an ED official said. The central agency launched its probe after the Mumbai Police registered a case in December 2024, alleging that Joshi had misused confidential trading information to cheat investors. The ED said several other traders and brokers are also under the scanner for allegedly participating in the scheme and generating illicit profits.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store